CTEV
CTEV
NYSE · Health Care

Claritev Corp

$25.55
-1.27 (-4.74%)
Financial Highlights (FY 2026)
Revenue
1.18B
Net Income
-348,800,997
Gross Margin
73.7%
Profit Margin
-29.5%
Rev Growth
-3.7%
D/E Ratio
53.83
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 73.7% 73.7% 52.6% 52.6%
Operating Margin 2.1% 1.9% 17.6% 18.2%
Profit Margin -29.5% -28.0% 10.3% 11.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.18B 1.23B 120.97M 144.20M
Gross Profit 873.58M 906.77M 63.60M 75.82M
Operating Income 24.64M 23.02M 21.32M 26.23M
Net Income -348,800,997 -325,846,893 12.43M 17.02M
Gross Margin 73.7% 73.7% 52.6% 52.6%
Operating Margin 2.1% 1.9% 17.6% 18.2%
Profit Margin -29.5% -28.0% 10.3% 11.8%
Rev Growth -3.7% -3.7% +3.8% +22.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 224.80M 224.80M 70.38M 71.42M
Total Equity 4.18M 4.18M 318.69M 313.69M
D/E Ratio 53.83 53.83 0.22 0.23
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 571.12M 563.18M 29.22M 37.67M
Free Cash Flow — — 8.49M 13.89M